138 related articles for article (PubMed ID: 9021916)
41. [Enhancement of the immune response in mice with a noval HCV DNA vaccine targeting NS3 to dendritic cells].
Yin X; Wang W; Tan WJ; Deng Y; Guan J; Wen B; Chen H; Ruan L
Bing Du Xue Bao; 2011 Jan; 27(1):44-9. PubMed ID: 21462505
[TBL] [Abstract][Full Text] [Related]
42. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
Sin JI; Kim JJ; Zhang D; Weiner DB
Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
[TBL] [Abstract][Full Text] [Related]
43. Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liver.
Rogers JV; Hull BE; Fink PS; Chiou HC; Bigley NJ
Vaccine; 2000 Feb; 18(15):1522-30. PubMed ID: 10618550
[TBL] [Abstract][Full Text] [Related]
44. Multi-antigenic DNA immunization using herpes simplex virus type 2 genomic fragments.
Braun RP; Dong L; Jerome S; Herber R; Roberts LK; Payne LG
Hum Vaccin; 2008; 4(1):36-43. PubMed ID: 18438102
[TBL] [Abstract][Full Text] [Related]
45. Impact of timing strategy of LIGHT, a new TNF superfamily on immune platform induced by HSV-1 gB DNA vaccine.
Pouyanfard S; Bamdad T; Parsania M; Hashemi H; Mohammadi MG
Cytokine; 2010 Apr; 50(1):99-103. PubMed ID: 20097089
[TBL] [Abstract][Full Text] [Related]
46. Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis.
Hu K; He X; Yu F; Yuan X; Hu W; Liu C; Zhao F; Dou J
Immunol Invest; 2011; 40(3):265-78. PubMed ID: 21204603
[TBL] [Abstract][Full Text] [Related]
47. The dominant roles of ICAM-1-encoding gene in DNA vaccination against Japanese encephalitis virus are the activation of dendritic cells and enhancement of cellular immunity.
Zhai YZ; Zhou Y; Ma L; Feng GH
Cell Immunol; 2013 Jan; 281(1):1-10. PubMed ID: 23411485
[TBL] [Abstract][Full Text] [Related]
48. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
[TBL] [Abstract][Full Text] [Related]
49. [Vaccines against herpex simplex virus infections. What's new].
Hoeller Obrigkeit D; Baron JM
Hautarzt; 2007 May; 58(5):465-6. PubMed ID: 17450340
[No Abstract] [Full Text] [Related]
50. Immunization with HSV-2 gB-CCL19 Fusion Constructs Protects Mice against Lethal Vaginal Challenge.
Yan Y; Hu K; Deng X; Guan X; Luo S; Tong L; Du T; Fu M; Zhang M; Liu Y; Hu Q
J Immunol; 2015 Jul; 195(1):329-38. PubMed ID: 25994965
[TBL] [Abstract][Full Text] [Related]
51. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
52. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity.
Toka FN; Rouse BT
J Leukoc Biol; 2005 Jul; 78(1):178-86. PubMed ID: 15817700
[TBL] [Abstract][Full Text] [Related]
53. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
[TBL] [Abstract][Full Text] [Related]
54. DNA vaccine-encoded glycoprotein B of HSV-1 fails to protect chronic morphine-treated mice against HSV-1 challenge.
Jamali A; Roostaee MH; Soleimanjahi H; Ghaderi Pakdel F; Bamdad T
Comp Immunol Microbiol Infect Dis; 2007 Mar; 30(2):71-80. PubMed ID: 17126902
[TBL] [Abstract][Full Text] [Related]
55. Enhancement of antibody response by high mobility group box protein-1-based DNA immunization.
Kimura R; Shiibashi R; Suzuki M; Hayashizaki Y; Chiba J
J Immunol Methods; 2010 Sep; 361(1-2):21-30. PubMed ID: 20470779
[TBL] [Abstract][Full Text] [Related]
56. The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine.
Kusakabe K; Xin KQ; Katoh H; Sumino K; Hagiwara E; Kawamoto S; Okuda K; Miyagi Y; Aoki I; Nishioka K; Klinman D; Okuda K
J Immunol; 2000 Mar; 164(6):3102-11. PubMed ID: 10706700
[TBL] [Abstract][Full Text] [Related]
57. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
Sedegah M; Weiss W; Sacci JB; Charoenvit Y; Hedstrom R; Gowda K; Majam VF; Tine J; Kumar S; Hobart P; Hoffman SL
J Immunol; 2000 Jun; 164(11):5905-12. PubMed ID: 10820272
[TBL] [Abstract][Full Text] [Related]
58. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
59. Involvement of an ATP-dependent peptide chaperone in cross-presentation after DNA immunization.
Kumaraguru U; Rouse RJ; Nair SK; Bruce BD; Rouse BT
J Immunol; 2000 Jul; 165(2):750-9. PubMed ID: 10878348
[TBL] [Abstract][Full Text] [Related]
60. Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha.
Tüting T; Wilson CC; Martin DM; Kasamon YL; Rowles J; Ma DI; Slingluff CL; Wagner SN; van der Bruggen P; Baar J; Lotze MT; Storkus WJ
J Immunol; 1998 Feb; 160(3):1139-47. PubMed ID: 9570527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
